The Quantitative Proteomics core will provide high-end mass spectrometry based proteomic support to the P01 Project team members to help identify and quantify protein expression and post-translational modifications (PTMs) on histone and non-histone proteins from various cell lines and brain tumors. Histones are small proteins that help organize eukaryotic DNA information into nucleosomes, the repeating building blocks of chromatin. Gene regulation modulated via chromatin remodeling is achieved by the addition of PTMs to histones or by the incorporation of specialized histone variant members. Dysregulation of these pathways have been identified in many human disorders and cancers. Most histone related research work is centered on the use of antibodies that recognize a single histone PTM (Western blot, immunofluorescence, etc.). However, these types of experiments have drawbacks such as cross-reactivity, potentially limited specificity, and cannot be used to discover novel histone PTMs. Additionally, these antibodies often have issues with the recognition of their intended single modification site in modification-dense regions, a phenomenon known as epitope occlusion. Here we will use our novel mass spectrometry based proteomics platforms and integrated bioinformatics to comprehensively interrogate the PTM profiles of histones extracted from model cell lines, primary cells and tumor tissue harboring histone mutations. These experiments will allow for precise measurement of the abundance of over 100 different histone modification and variant proteoforms. Additionally, the Garcia lab has produced arguably the best platform for analysis of combinatorial histone modifications to determine crosstalk relationships between different modified sites. Studies aimed to isolate chromatin from specific cancer related genes will also be performed to understand the local histone environment contributing to tumoregenesis. We will also perform experiments to identify proteins that bind to specific cancer enriched histone PTMs (e.g. histone readers), or non-histone proteins that are modified themselves and may affect chromatin networks that modulate crucial gene expression programs.

Public Health Relevance

Mutation to histone genes have been found in different types of cancers. This research will help define altered chromatin pathways due to these mutations, thus laying down the foundation for potential development of novel targeted drug therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA196539-05
Application #
9773978
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-09-01
Budget End
2020-08-31
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Guo, Qi; Sidoli, Simone; Garcia, Benjamin A et al. (2018) Assessment of Quantification Precision of Histone Post-Translational Modifications by Using an Ion Trap and down To 50?000 Cells as Starting Material. J Proteome Res 17:234-242
Weiner, Amber K; Sidoli, Simone; Diskin, Sharon J et al. (2018) Graphical Interpretation and Analysis of Proteins and their Ontologies (GiaPronto): A One-Click Graph Visualization Software for Proteomics Data Sets. Mol Cell Proteomics 17:1426-1431
Gomes, Carolina Cavalieri; Gayden, Tenzin; Bajic, Andrea et al. (2018) TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw. Nat Commun 9:4572
Shastrula, Prashanth Krishna; Lund, Peder J; Garcia, Benjamin A et al. (2018) Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms. J Biol Chem 293:12360-12377
Bharathy, Narendra; Berlow, Noah E; Wang, Eric et al. (2018) The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma. Sci Signal 11:
Lin-Shiao, Enrique; Lan, Yemin; Coradin, Mariel et al. (2018) KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis. Genes Dev 32:181-193
Aebersold, Ruedi; Agar, Jeffrey N; Amster, I Jonathan et al. (2018) How many human proteoforms are there? Nat Chem Biol 14:206-214
Yuan, Zuo-Fei; Sidoli, Simone; Marchione, Dylan M et al. (2018) EpiProfile 2.0: A Computational Platform for Processing Epi-Proteomics Mass Spectrometry Data. J Proteome Res 17:2533-2541
Zhang, Hanghang; Pandey, Somnath; Travers, Meghan et al. (2018) Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer. Cell 175:1244-1258.e26
Kreher, Jeremy; Takasaki, Teruaki; Cockrum, Chad et al. (2018) Distinct Roles of Two Histone Methyltransferases in Transmitting H3K36me3-Based Epigenetic Memory Across Generations in Caenorhabditis elegans. Genetics 210:969-982

Showing the most recent 10 out of 63 publications